期刊文献+

胸部放疗在广泛期小细胞肺癌治疗中的应用分析 被引量:2

Application of Thoracic Radiotherapy in the Treatment of Extensive Stage Small Cell Lung Cancer
下载PDF
导出
摘要 目的观察在广泛期小细胞肺癌治疗中胸部放疗的效果以及可行性。方法选择患有广泛期小细胞肺癌的患者60例,将患者随机分为两组,观察组患者进行同步放化疗,对照组患者仅进行单纯化疗,对两组患者治疗效果以及不良反应发生率等情况进行对比。结果观察组患者在总有效率、不良反应发生率等方面均优于对照组患者,并且两组相比差异具有统计学意义(P<0.05)。结论在广泛期小细胞肺癌治疗中使用胸部放疗具有很好的效果,同时不良反应发生率低,因此具有一定的可行性。 Objective To observe the effect and feasibility of thoracic radiotherapy in the treatment of extensive stage smal cel lung cancer.MethodsSixty patients were extensive stage smal cel lung cancer patients,randomly divided into two groups,patients in study group were treated with radiotherapy and chemotherapy,patients in the control group only with chemotherapy,rate of the therapeutic effect of two groups of patients,and adverse reactions were compared.Results Patients in the observation group were better than the control group in total effective rate,adverse reaction rate, and the two groups had significant difference(P〈 0.05).Conclusion In the treatment of extensive stage smal cel lung cancer with good results,but the incidence of adverse reactions is low,so it has a certain feasibility.
作者 刘相海
机构地区 吉林省人民医院
出处 《中国卫生标准管理》 2015年第20期12-13,共2页 China Health Standard Management
关键词 胸部放疗 广泛期小细胞肺癌 疗效 可行性 Thoracic radiotherapy Extensive stage smal cel lung cancer Curative effect Feasibility
  • 相关文献

参考文献3

二级参考文献32

  • 1宋丽华,宋现让,张锡芹,齐洁琳,李秀菊,田禾,步兵.小细胞肺癌患者预后因素分析[J].中华肿瘤杂志,2004,26(7):413-416. 被引量:23
  • 2陈东福,吕纪马,周宗枚,王绿化,张宏兴,冯勤富,梁军,肖泽芬,张世平,张香茹,殷蔚伯.放射治疗在广泛期小细胞肺癌治疗中的影响[J].医学研究杂志,2006,35(4):15-17. 被引量:16
  • 3Govindan R,Page N,Morgensztern D,et al.Changing epidemiology of small-cell lung cancer in the United States over the last 30 years:analysis of the surveillance,epidemiologic,and end results database.J Clin Oncol,2006,24:4539-4544.
  • 4Baymana NA,Sheikh H,Kularatne B,et al.Radiotherapy for small-cell lung cancer:where are we heading? Lung Cancer,2009,63:307-314.
  • 5Komaki R.Combined treatment for limited small cell lung cancer.Semin Oncol,2003,30(4 Suppl 9):56-70.
  • 6O'Brien ME,Ciuleanu TE,Tsekov H,et al.Phase Ⅲ trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer.J Clin Oncol,2006,24:5441-5447.
  • 7Allen J,J ahanzeb M.Extensive-stage small-cell lung cancer:evolution of systemic therapy and future directions.Clin Lung Cancer,2008,9:262-270.
  • 8Socinki MA,Smit EF,Lorigan P,et al.Phase Ⅲ study of pernetrexed plus carboplatin compared with etoposide plus carboplatin in chemotherapy-naive patients with extensive-stage small-cell lung cancer.J Clin Oncol,2009,27:4787-4792.
  • 9Lara PN Jr,Natale R,Crowley J,et al.Phase Ⅲ trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer:clinical and pharmacogenomic results from SWOG S0124.J Clin Oncol,2009,27:2530-2535.
  • 10Eckert F,Müller AC.SCLC extensive disease:treatment guidance by extent or/and biology of response? Radiat Oncol,2008,3:33.

共引文献13

同被引文献10

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部